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Abstract
Background: Helicobacter pylori is associated with chronic gastritis, peptic ulcers, and gastric cancer. Two major
virulence factors of H. pylori have been described: the pathogenicity island cag (cag PAI) and the vacuolating
cytotoxin gene (vacA). Virtually all strains have a copy of vacA, but its genotype varies. The cag PAI is a region of
32 genes in which the insertion of IS605 elements in its middle region has been associated with partial or total
deletions of it that have generated strains with varying virulence. Accordingly, the aim of this work was to
determine the cag PAI integrity, vacA genotype and IS605 status in groups of isolates from Mexican patients with
non-peptic ulcers (NPU), non-bleeding peptic ulcers (NBPU), and bleeding peptic ulcers (BPU).
Methods: The cag PAI integrity was performed by detection of eleven targeted genes along this locus using dot
blot hybridization and PCR assays. The vacA allelic, cag PAI genotype 1 and IS605 status were determined by PCR
analysis.
Results: Groups of 16-17 isolates (n = 50) from two patients with NPU, NBPU, and BPU, respectively, were studied.
90% (45/50) of the isolates harbored a complete cag PAI. Three BPU isolates lacked the cag PAI, and two of the
NBPU had an incomplete cag PAI: the first isolate was negative for three of its genes, including deletion of the
cagA gene, whereas the second did not have the cagM gene. Most of the strains (76%) had the vacA s1b/m1
genotype; meanwhile the IS605 was not present within the cag PAI of any strain but was detected elsewhere in
the genome of 8% (4/50).
Conclusion: The patients had highly virulent strains since the most of them possessed a complete cag PAI and
had a vacA s1b/m1 genotype. All the isolates presented the cag PAI without any IS605 insertion (genotype 1).
Combined vacA genotypes showed that 1 NPU, 2 NBPU, and 1 BPU patients (66.6%) had a mixed infection;
coexistence of H. pylori strains with different cag PAI status was observed in 1 NBPU and 2 BPU (50%) of the
patients, but only two of these patients (NBPU and BPU) had different vacA genotypes.
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Introduction
H. pylori is a well-recognized pathogen that chronically
infects the stomach of up to 50% of the world’sh u m a n
population. The prevalence of H. pylori is high in devel-
oping countries; in Mexico its seroprevalence is 66% of
the general population and is common in asymptomatic
population [1-5].
There are two genotypic characteristics of virulent H.
pylori strains: the vacA gene, and the cag PAI region.
Virtually all H. pylori strains have a copy of vacA,b u t
the structure among alleles varies in three regions: the
signal (s) region that is present as type s1 (subtype a, b
and c) or type s2, the intermediate (i) region that exists
in subtype 1 and 2, and the middle (m) region that
exists in three different allelic forms (m1, m2a, and
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sive allelic diversity where all combinations of all those
regions have been reported. The s1/m1 genotype
encodes a VacA protein, which possesses high vacuolat-
ing cytotoxin activity and is associated with severe gas-
troduodenal diseases [6-9]. Infection by multiple H.
pylori strains, defined by different vacA genotypes, is
c o m m o ni nM e x i c o .N e v e r t h e l e s s ,t h em o s tp r e v a l e n t
vacA genotypes in the Mexican population are s1(b)/m1
and s2/m2, which have been associated with the devel-
opment of chronic gastritis (CG), peptic ulcers (PU),
and gastric cancer (GC) [10-17].
cag PAI encodes components of a type IV secretion
system (T4SS), which is used for the translocation of
CagA into the gastric epithelium cells, where it is phos-
phorylated. Phosphorylated CagA interferes with various
physiological transduction signals in the host cell and
causes pathological cellular responses that contribute to
the development of local inflammation and the damage
of the gastric mucosa. The elimination of T4SS function
significantly reduces the accumulation of phosphorylated
CagA in the host cell and the secretion of interleukin 8
(IL-8) [18]. The presence of cag PAI has been associated
with the development of CG, PU, and GC [19].
In Mexico, studies of cag PAI and its relationship with
the infection outcomes have focused on the cagA gene
and its product, protein CagA, which have been used as
biomarkers of this genetic region. These studies have
shown a correlation between serologic detection of anti-
bodies against CagA and the identification of the infect-
ing H. pylori cagA+ strains [2-4,12,20,21]. A series of
studies have shown a close association between CagA
antibodies and the development of gastroduodenal
pathologies such as PU and GC [12,22,23]. The presence
of cagA as a biomarker for cag PAI and gastric coloniza-
tion with cagA+ strains associated with gastrointestinal
diseases has been documented by PCR in isolated bac-
terial DNA and has also been detected by hybridization
in situ from biopsies or by microarray hybridization
[4,5,10-12,14-16,24,25].
Nevertheless, many studies have demonstrated that
T4SS integrity is needed for translocation of CagA pro-
tein into gastric epithelium cells and that the insertion
of IS605 elements between cag I and cag II of cag PAI
has been implicated in partial or total deletions that
have generated H. pylori strains with varying virulence
[26,27].
In Mexico three studies have addressed the correlation
between genetic integrity in cag PAI in multiple isolates
obtained from individual patients with gastroduodenal
diseases. One study characterized the vacA genotypes
and evaluated the presence of cag PAI by PCR amplifi-
cation of the cagA in four children with chronic abdom-
inal pain (CAP), eight adult patients with PU and one
with non-ulcer dyspepsia (NUD). This study also char-
acterized the diversity of cag PAI by microarray geno-
typing in 51 isolates from three of the adult with PU
and four of the pediatric patients [16]. The second study
showed homogeneous cag PAI+ content in eight adults
and ten pediatric patients with CAP, PU or NUD, after
evaluating the presence of cagA, cagE, cagT and cag10
genes by PCR [25]. The third study, which used DNA
microarrays, showed that the presence of a complete cag
PAI was significantly more frequent for isolates from
patients with GC than for isolates from non-atrophic
gastritis (NAG) and duodenal ulcer (DU) patients [5].
Nevertheless, the integrity of cag PAI and vacA geno-
types as important contributors to the risk of PU devel-
opment, and its most common complication, BPU, had
not previously been studied in the Mexican population.
Accordingly, the goal of this work was to establish the
cag PAI,v a c Aa n dIS605 status in groups of single-col-
ony isolates from Mexican patients with non-peptic
ulcers and (bleeding or not bleeding) peptic ulcers.
Methods
Study subjects
Two patients with gastric or duodenal ulcers with
ongoing or recent (24 h) bleeding (BPU) were recruited
and the gastric biopsy samples from each were taken
into the first 24 hours. Four additional patients were
included in the study as controls: two patients with
NBPU and two on whom an endoscopy was performed
because of non-ulcer dyspepsia and/or gastro-esophageal
reflux (NPU). None of the patients had clinical history
of mucosa associated lymphoid tissue (MALT) lym-
phoma or Crohn’s disease. 50 clinical H. pylori isolates
were obtained from biopsy specimens: 17 (8 and 9)
from the two patients with BPU; 17 (12 and 5) from the
two patients with NBPU, and 16 (9 and 7) from the
patients with NPU. All six patients were recruited from
a Mestizo-Mexican population in a previous cross-sec-
tional, prospective, observer-blind study carried out
between November 1995 and August 1997 [4]. The sub-
jects ranged from 53 to 72 years old (mean 61 years),
and the F/M sex ratio was 1:1 in the NBPU and NPU
groups and 0:2 in the BPU group. At least seven biop-
sies from the antral and corpus gastric mucosa were
taken during the same endoscopic sessions of each
patient.
H. pylori culture and chromosomal DNA extraction
H. pylori was cultured by smearing biopsy specimens on
the surfaces of horse blood agar plates. The colonies
obtained were identified as H. pylori according to stan-
dard criteria, including typical cell morphology, negative
Gram staining, and biochemical testing. The rest of the
colonies from each plate were harvested in batches to
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9 and 12 colonies were picked separately from these
plates and were then passed onto individual plates. Each
of these plates was propagated three more times for the
obtaining of biomasses and extraction of chromosomal
DNAs as previously reported [10]. In the current study
these chromosomal DNAs were used to carry out all the
genotyping assays after their characterization by PCR
amplification of the H. pylori 16S rRNA gene, using the
HP16-219 and HPGR-16S pair of primers (see Table 1).
PCR Primer Design
Using the genome sequence of the H. pylori 26695 strain
as reference (ATCC 700392) [GenBank: AE000511.1]
[28], pairs of primers were designed to carry out specific
PCR amplifications for one or two of selected genes from
the region cag I: cag6, cag6-7, cag10, cag13 and cag16,
cagT and cagS; and from the cag II region of cag PAI:
cagQ, cagM, cagI, cagE and cagA [26,27]. The cagS-Q-F
and cagS-Q-R pair of primers was designed to amplify
the DNA cagS-Q fragment and to detect the presence of
the IS605 between the cag Ia n dcag II regions of cag
PAI. The TnpB-cagSF and TnpB-cagSR primers were
designed to detect the IS605 contiguous to the cag
II region that characterizes the genotype 2 of cag PAI
previously reported [26]. To determine if IS605 was pre-
sent elsewhere in the genome, the primers IS605F and
IS605R were used. For amplification of cagA, the primers
Table 1 Primers used in this study for H. pylori genotyping.
Primer Sequence (5’-3’) Size of amplified
fragment
Annealing
temperature °C
Position in genome of reference
(H. pylori 26695)*
16S rRNA
HPGF-16S CAATCAGCGTCAGTAATGTTC 516 55 1208359-1208379
HPGR-16S CTAAGAGATCAGCCTATGTCC 1208855-1208875
cag PAI
genes
cag1-F TTCATTAGGTCTCATTGGAGCAGG 230 62 547429-547452
cag1-R TTGGCTTCAGTTGGTTCGTTG 547639-547659
cag1-F TTCATTAGGTCTCATTGGAGCAGG 430 66 547429-547452
cag1-2-R CCCTTACAGCCGCCTTTATTTAC 547837-547859
cag5-F CGCCACTCTTATCTTCTTCACCTC 645 66 551152-551175
cag5-R GGGGATTTTATCGCTTACGCAG 551776-551797
cag7-F AAGCGTGTCATAATGGGTGTGC 986 66 554726-554747
cag7-R AGAAAAGGCTGTTGCGGATTG 555692-555712
cag9-F ATGTCCCCCCAACAAATCGC 627 62 562353-562372
cag9-R CCATTAGCCACAAGTTTAGCCG 562959-562980
cagT-F GTTCACCATTCTAAAAAGATTACGC 555 66 565331-565355
cagT-R GATTTCGCAAGTATTCATTCTCTC 565863-565886
cagS-F CAATGGTTTTTAGATTAGCG 342 54 566203-566222
cagS-R AAGGGAGCGTTAGATAAGG 566527-566545
cagS-Q-F TCTAACGCTCCCTTGTTTGTATGC 687 66 566532-566555
cagS-Q-R TTGGTTGGTAATGGTTTTGGTAGC 567196-567219
cagQ-F CCAAAACCATTACCAACCAAAGC 292 66 567200-567222
cagQ-R CCGAACAAGCAAGAACTTACACAAC 567468-567492
cagM-F GGTTGCGTTTGGAGTTTTGTCG 485 66 568752-568773
cagM-R TGAGCCTTATCTTTAGTGGTAGCGG 569213-569237
cagI-F TGTTCTTCCCAAAGGTCGGC 510 62 571644-571663
cagI-R CTTCTGACAACGCTCAATACATCG 572131-572154
cagE-F AGTGATGCTTTGAGTCGCAAGTC 923 64 575506-575528
cagE-R TGGGGCAATAGTGTGATGACG 576409-576429
cagA-F GCCTAATTTAAATAATCTCGCTATCAC 744 55 581555-581581
cagA-R ATTGAGATTGTCAACTTTATCCG 582277-582299
IS605-F TTTGATAAAAACGGATGTGTGG 1,016 55 13986-14007 (AC000108)#
IS605-R TGTTTTTGCAATAAGGGGAT 14983-15002
TnpB-cagS-F CGTTCTTAAGCCCATGTCTAAACC 1,597 56 14038-14061 (AC000108)#
TnpB-cagS-R TCTAACGCTCCCTTGTTTGTATGC 15612-15635
*[GenBank: AE000511.1]; #[GenBank: NCTC11638].
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sequence of a set of 26 cagA gene-sequences reported
[GenBank: AB015404-16; AF202972-3; AB011791-2;
AF249275; AF001357; L11714; AF083352; AF282853;
AF247651; AE001483 and AB003397], using the MacVec-
tor 2.1 molecular biology program. Table 1 shows the
nucleotide sequence of PCR primers used for the genera-
tion of all these DNA-fragments. The parameters for the
amplification of IS605 in the genome were 94°C for 45
seconds, 54°C for 1 minute and 30 seconds, and 72° C
for 1 minute and 30 seconds, for a total of 30 cycles. The
amplification parameters for DNA fragment cagS-Q were
94°C for 1 minute, 50°C for 1 minute, 72°C for 2 minutes,
for a total of 30 cycles.
Cloning of the cag PAI genes
Eleven DNA fragments corresponding to individual
selected cag PAI genes and two DNA fragments that
included the cag6-7 and cagS-cagQ genes were gener-
ated by PCR. The thermal cycling conditions were at 94°
C for 30 seconds, the primer annealing temperature ran-
ging from 54-66°C (depending on the melting tempera-
ture of each set of primers that were used; see Table 1)
for 30 seconds, and 72°C for 30 seconds, for a total of
30 cycles. The PCR products were cloned directly into
the linearized pCR
®2.1-TOPO
® vector to obtain a
genetic library of cag PAI formed by thirteen plasmids.
The thirteen cloned fragments showed 100% identity in
their nucleotide sequence when they were compared
with the reported sequence of the H. pylori strain
26695, using the BLAST program.
Southern blot hybridization
For all the H. pylori strains and controls, 500 μgo f
genomic DNA were transferred to a nylon membrane
(Hybond-N+) with sodium hydroxide. The genomic
DNAs were hybridized with each one of the plasmids
of the genetic library of cag PAI, which were pre-
viously digested with the EcoR Io v e r n i g h ta t3 7 ° C .T h e
plasmid DNAs were labelled with thermostable alkaline
phosphatase, Alkphos Direct Labelling and Detection
System and CDP-Star (Amersham Pharmacia Biotech).
The membrane was pre-hybridized for 2 hours at 55°C,
and hybridized at 55°C overnight. The membrane was
washed three times at 58°C, in a shaking water bath
for 15 minutes, transferred to a clean container and
washed twice with secondary wash solution for 10
minutes at room temperature. Excess of wash solution
was removed from the membrane and the CDP-Star
substrate was added and incubated at room tempera-
ture for 5 minutes. Afterwards the membrane was
wrapped in plastic film and autoradiography was per-
formed with a sheet of Hyperfilm™ ECL (Amersham
Pharmacia Biotech) at different lengths of time. The
membranes were stripped from the previously hybri-
d i z e dp r o b ea n ds t o r e di nh y b r i d i z a t i o nb a g sa t4 ° Ct o
be used with another probe.
vacA genotyping by specific PCR amplification
The vacA signal and middle regions were typed by using
the primers as described previously by Atherton et al.
[6]. The isolates were at first identified as type s1 or s2
and type m1 or m2. All strains with signal region type
s1 were further characterized into s1a or s1b variants by
performing three separate PCR assays. H. pylori 26695
(cag PAI+, vacA s1a/m1), J99 (ATCC 700824) (cag PAI
+, vacA s1b/m1), Tx30a (ATCC 51932) (cag PAI-, vacA
s2/m2), and 86-313 (cag PAI-, vacA s2/m2) strains were
used as controls for vacA allele detection [28-30]. Dis-
tilled water was used as an internal-reaction negative
control. Thermal cycling conditions for each set of pri-
mers (0.5 μM) were at 95 °C for 1 minute, 52 °C for 1
minute, for a total of 35 cycles.
Results
We investigated the integrity of cag PAI, vacA alleles,
and the presence of IS605 in groups of single-colony
isolates from three pairs of Mexican patients with NPU,
NBPU, and BPU. To analyze the integrity of the cag PAI
region of groups of 5-12 single-colonies (n = 50), South-
ern blot hybridizations were performed. The analysis
was based on the detection of eleven targeted genes
homogeneously distributed along this locus using the
cag PAI genetic library as a probe. An example of detec-
tion of the cagA gene by hybridization is illustrated in
Figure 1. To confirm the result of the hybridizations,
the genomic DNAs were used for detection of cagA
gene by PCR using the pairo fc o n s e n s u sp r i m e r s
described in Table 1. The percentage of detection of
cagA gene by PCR, with respect to those identified by
hybridization, was 97.7%. Thus, a gene marker was
defined as positive if it was detected by dot blot and not
by PCR. The results showed that 90% (45/50) of the iso-
lates were positive for all of the studied genes of cag
PAI, whereas 4% (2/50) and 6% (3/50) had an incom-
plete cag PAI or were negative for all the analyzed
genes, respectively. Co-existence of strains with different
cag PAI status was observed in 50% (3/6) of the patients
(see Table 2). 2 BPU patients were infected with multi-
ple strains, some of which had a complete cag PAI, and
others that didn’t: 1/8 (12.5%) and 2/9 (25%), respec-
tively. Meanwhile, 1 NBPU patient was infected with
strains with a complete cag PAI but also with strains
with an incomplete island 2/12 (16%). One of these
strains showed deletions of the cagW, cagT, cagI, includ-
ing deletion of the cagA gene, while the other did not
have the cagM gene. Thus, the presence of the complete
cag PAI was found in 100% (16/16); 88.2% (15/17);
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patients with NPU, NBPU, and BPU, respectively. The
results of the Southern hybridization were confirmed by
PCR amplifications of the eleven cag PAI gene markers
in the five strains that had the incomplete or lacked the
cag PAI. The PCR amplifications were similar to those
obtained by the hybridization method.
PCR analysis was performed in order to determine
whether the clinical isolates had a pathogenicity island
that was uninterrupted or one that was divided in two
regions as the result of insertion of a single-copy of
IS605 element, similar to genotypes 3 described pre-
viously [26]. These PCR assays were carried out using
specific primers for sites upstream and downstream of
this insertion (cagS-Q-F and cagS-Q-R; Table 1) to
amplify the cagS-Q D N Af r a g m e n t .D N Af r a g m e n t so f
2,567 pb or 687 pb were predicted whether or not the
cag PAI was split by an IS605 element. The results of
this analysis showed the presence of a cagS-Q fragment
of 687 pb in 100% (16/16) of the isolates of the patients
with NPU. In the group of patients with BPU, 70.5%
(12/17) of the isolates resulted positive for this DNA
fragment. Three fifths (3/5) of isolates that were nega-
tive for this DNA fragment were also negative for the
cag PAI by dot blot hybridization (11.7%) (cag PAI- iso-
lates; see Table 2).The 2/5 remaining BPU isolates were
negative for the cagS-Q DNA fragment, even though
they were positive for cagSa n dcagQ genes by dot blot
hybridization. Similarly, one isolate from a NBPU
patient (1/9) was negative for this fragment but positive
for cagS and cagQ genes by Southern blot. PCR amplifi-
cations were performed in order to rule out the possibi-
lity that these three strains may have had an IS605-
based rearrangement in the island similar to genotype
2 in the NCTC 11608 strain (where the cag Ia n d
cag II regions are separated by a large fragment of chro-
mosomal DNA flanked by two IS605 sequences) [26,27].
The tnpB-cagS-F and tnpB-cagS-R primers were used to
amplify a 1,597 pb DNA fragment between the cagS
gene and the tnpB transposases of the adjacent IS605,
 
Figure 1 Detection of the cagA gene by Southern blot
hybridization. (A) Hybridization for 50 genomic DNA of the isolates
and 4 H. pylori reference strains as positive and negative controls, as
well as a control the plasmid with the intra-cagA gene cloned, and
distilled water as an internal-reaction negative control. (B) Schematic
representation of the result of hybridization: circles continuous and
discontinuous for positive and negative hybridization, respectively.
Abbreviations: CTLS, controls; NPU, non-peptic ulcers; NBPU, non-
bleeding peptic ulcers, and BPU, bleeding peptic ulcers.
Table 2 Association between integrity cag PAI, IS605, and vacA genotype of H. pylori.
vacA genotype
cagPAI IS605 present
outside cag PAI
Non-peptic ulcers Non-Bleeding Peptic ulcers Bleeding peptic ulcers Total %
of isolates
Patient 1 Patient 2 Patient 1 Patient 2 Patient 1 Patient 2
CP + - s1b/m1
(9)*
s1b/m2 (5), s0/
m1 (1)
s1b/m1 (7) s2/
m2 (1),
s1b/m1 (3), s1b/m2 (1),
s0/m1 (1)
s1b/m1 (7) s1b/m1 (6),
s1b/m0 (1)
84
CP + + s1b/m2 (1) s1b/m1 (2) 6
CP - - s1b/m1 (1) s1b/m1 (2) 6
CP +/- + s0/m1 (1) 2
CP +/- - s1b/m1 (1) 2
( )*, numbers of isolates; CP+, complete; CP-, without; CP+/-, incomplete; s0, untypeable for signal region; m0, untypeable for middle region. Patient No.1: Mestizo
female, 54 years old, without peptic ulcers or ulcer history; patient No 2: Mestizo male, 53 years old, without peptic ulcers or ulcer history; patient No 3: Mestizo
male, 63 years old, with ulcer history, non-bleeding duodenal ulcers; patient No 4: Mestizo female, 65 years old, with ulcer history, non-bleeding duodenal ulcers;
patient No 5: Mestizo male, 61 years old, without ulcer history, bleeding duodenal ulcers; patient No 6: Mestizo male, 72 years old, with ulcer history, bleeding
gastric ulcers.
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IS605 insertion sequence was not found, and it can
therefore be assumed that the cag PAI was presented as
an uninterrupted unit in 94% (47/50) of the analyzed
isolates (cag PAI 1 genotype) [26].
In this study, 2 strains (4%) presented partial deletions
of cag PAI. The presence of IS605 anywhere in the
H. pylori chromosome is thought to be involved in cag
deletions [26].To determine whether or not the clinical
isolates had the IS605 insertion elsewhere in the chro-
mosome, the IS605-F and IS605-R primers were used to
amplify a tnpA-tnpB DNA fragment of 1,016 pb. The
results of this analysis showed that the IS605 insertion
was present in 8% (4/50) of the isolates. One isolate
with a complete cag PAI was present in a patient with
NPU, and three isolates were present in only one patient
with NBPU: two of the isolates had a complete cag PAI
and another had an incomplete cag PAI. Thus, the com-
plete-cag PAI/IS605- genotype of the strains was predo-
minant in the different patients in this study.
To account for the possibility that the different
patients might have been infected with multiple strains
of H. pylori,w ei n v e s t i g a t e dt h evacA genotypes of the
clinical isolates. Three combinations of vacA sa n dm
regions were identified: 38 (76%) of the strains had the
s1b/m1 genotype that was previously described as the
most prevalent vacA genotype in Mexican populations
[10,14]. The second most frequent vacA genotype was
s1b/m2, which was present in 7 (14%) strains, whereas
the s2/m2 genotype, previously reported as the most
prevalent genotype in PU patients from north-eastern of
Mexico [11,12], was only present in 1 (2%) of NBPU iso-
lates. The s2/m1 genotype described previously was not
identified [10-12,15]. Untypeable vacA genotypes have
been previously described in Mexican populations. In
t h i ss t u d yw ef o u n d3( 6 % )s t r a i n sw h e r evacA region
m1 was amplified, but vacA s region was not detected
(1 NPU, and 2 NBPU isolates). Likewise, 1 BPU isolate
(2%) was s1b/m0, which accounts for the possibility that
an additional subfamily of s and m genotypes might
exist in Mexican isolates, given that in this study as in
those reported elsewhere in México, the s1c and m3
vacA alleles, which have been described in some popula-
tions [31], were not investigated [10,11,14,17]. In this
study, evidence of infection by more than one H. pylori
strain was found in 66.6% (4/6) of the patients, where at
least two vacA allotypes were detected. This confirms
the multi-strain nature of the H. pylori infection pre-
viously described in the Mexican population [10,12-14]
(see Table 2).
Discussion
In this study which used eleven selected cag PAI genes
as a probe to carry out the characterization of cag PAI
by Southern blot hybridization, we found that among
the 50 H. pylori isolates, a completed cag PAI was
detected in 45 (90%) of them; 2 (4%) presented an
incomplete cag PAI, whereas in 3 (6%) the cag PAI was
not detected. Thus, most of our isolates possessed a
complete cag PAI. Three previous Mexican studies are
consistent with our results. The first of these, which
evaluated the presence of four cag PAI genes markers
by PCR assays, showed that 78.6% of the studied iso-
lates had a complete cag PAI, while 15.1% did not have
it, and 6.2% had partial deletions [25]. The second
study, which used hybridization microarrays to charac-
terize this genetic locus, showed that 18/29 (62%) of the
studied isolates had a complete cag PAI [5]. Neverthe-
less, these two studies and those previously published
about the Mexican population did not carry out the
correlation between the integrity of cag PAI and vacA
genotypes. Our data showed that 90% of the strains had
a complete cag PAI and that the major vacA s1b/m1
and s1b/m2 genotypes were present in 34/50 (68%) and
7/50 (14%) of the strains, respectively, whereas minor
s2/m2, s1b/m0 and s0/m1 genotypes were present in 1
(2%), 1 (2%) and 2 (4%). In 2/50 (4%) of the isolates
with an incomplete cag PAI, the s1b/m1 and s0/m1
genotypes were present. Meanwhile, the vacA genotype
was s1b/m1 in the 3/50 (6%) of the strains with an
undetected cag PAI. Thus, strains with a complete cag
PAI and vacA s1b/m1 genotype were the most com-
mon. In one of the NPU patients, the clinical isolates
were highly homogenous: 100% (9/9) of the isolates had
a complete island with a vacA s1b/m1 genotype (see
Table 2). Nevertheless, 4/6 (66.6%) of the studied sub-
jects had multiple genotype infections. The most notor-
ious of them was one of the NBPU patients who not
only had three strains with different vacA genotypes,
including the most prevalent genotype in north-eastern
of Mexico, the s2/m2, and untypeable s0/m1, but also
10/12 strains with a complete cag PAI, and 2/12 incom-
plete islands (see Table 2). One of these last strains
showed deletions of the cagW, cagT, cagI, including
deletion of the cagA g e n e ,w h i l et h eo t h e rs t r a i n ,t h e
cagM gene was deleted. In addition, this NBPU strain
represented 1/4 of the strains which had an IS605 inser-
tion somewhere in the chromosome. The deletions in
our isolates are quite different from that reported pre-
viously [5], which showed that almost 24% of the dele-
tion in cag PAI corresponded to the cag2 gene and has
been reported as nonessential for functional activity of
theT4SS [18].
Our data showed for first time that the 94% of the
Mexican isolates had the cag PAI genotype 1 described
previously [26], which did not have an IS605 insertion
between cagI and cagII regions; the remaining 6% of the
isolates lacked the cag PAI.
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The presence of the cag PAI and vacA genotypes in dif-
ferent subjects was analyzed according to disease group:
no differences were found between BPU and NBPU iso-
lates, in which the complete cag PAI was present in
88.2% and 82.3%, respectively. The presence of vacA
s1b/m1 genotype in NBPU (76%) is different when com-
pared with BPU (94%). Thus, we can conclude that
although the integrity of cag PAI is similar in NBUP
and BPU isolates, the presence of vacA s1b/m1 genotype
in BPU has a slightly higher presence when compared
with NBPU isolates.
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